Found 8 matching trials
Safety Study of MGAH22 in HER2-positive Carcinomas
PHASE1The purpose of this study is to determine if MGAH22 is safe when given by i...
Location
National Cancer Institute
Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer
PHASE1This main purpose of this clinical study is to learn about the safety and a...
Location
Yale School of Medicine
A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBC
PHASE1This is an open-label, Single-arm, Phase I clinical study to evaluate the p...
Location
The fifth medical center of the General Hospital of people's Liberation Army of China
Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer
PHASE3The purpose of this study is to determine whether patients with metastatic ...
Location
Ironwood Cancer & Research Center
Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer
PHASE2This is a Phase 2/3, randomized, open-label study for the treatment of pati...
Location
Mayo Clinic - Scottsdale
Margetuximab Plus Tucatinib and Capecitabine in HER2-positive Metastatic Breast Cancer
PHASE2This is a multicenter, open-label, single-arm, phase II clinical trial to e...
Location
Multiple Locations
A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC
PHASE2This is a randomized, open-label, multi-center, Phase II clinical study to ...
Location
National Taiwan University Hospital
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms
PHASE1The primary goal of this Phase 1 study is to characterize the safety and to...
Location
Banner MD Anderson Cancer Center